Article
Adverse reactions associated with the use of ustekinumab in Crohn's disease treatment:an analysis based on the FAERS database
2024-09-16
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Approved in 2016 for Crohn’s disease(CD), ustekinumab’s adverse reaction signals(ADRs) remain largely unclear. This study aims to enhance clinical safety by identifying ADRs through mining the FAERS database. <bold>Methods: </bold>We collected adverse drug event (ADE) data for ustekinumab used in the treatment of CD, reported in the FDA’s Adverse Event Reporting...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9b64085e-1ede-593e-b227-6b5e03ab315f
- DOI
- 10.21203/rs.3.rs-4880247/v1
